Regeneus Ltd (RGS.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
At close: 03:59PM AEST
| Previous close | 0.0570 |
| Open | 0.0550 |
| Bid | 0.0560 x 19973700 |
| Ask | 0.0610 x 27494300 |
| Day's range | 0.0540 - 0.0560 |
| 52-week range | 0.0410 - 0.0940 |
| Volume | |
| Avg. volume | 126,490 |
| Market cap | 17.16M |
| Beta (5Y monthly) | 0.26 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Will Weakness in Regeneus Ltd's (ASX:RGS) Stock Prove Temporary Given Strong Fundamentals?
It is hard to get excited after looking at Regeneus' (ASX:RGS) recent performance, when its stock has declined 8.8...
- ABN Newswire
Regeneus Ltd (RGS.AX) Research Collaboration with the Kolling Institute's Raymond Purves Bone and Joint Research Laboratory
Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, is pleased to announce a research collaboration with Professor Christopher Little and the Raymond Purves Bone and Joint Research Laboratory at the Kolling Institute at Royal North Shore Hospital, Australia.
© 2022 Yahoo. All rights reserved.
